Original document(25 pages) Authorized document(25 pages) 中文版
    The present invention relates to recombinant toxoplasma fusion protein, its preparation method and application. It utilizes gene engineering technology to prepare a new-type recombinant toxoplasma protein, i.e. the fusion protein formed from 110 amino acids from 43-th amino acid to 152-th amino acid of toxoplasma GRA6 protein N end and 258 amino acids from 56-th amino acid to 313-th amino acid of P30 protein which are series-connected. The above-mentioned 110 amino acids of GRA6 protein N end is positioned at fusion protein N end, and the 258 amino acids of P30 protein is positioned at C end of the fusion protein, and between them 2 amino acids of Gly and Ser are connected, and one methionine (Met) is added at N end of fusion protein, its total length has 371 amino acids.
Application Number
申请号
03113429 Application Date
申请日
2003.05.09
Title 名称 Recombinant Toxoplasma fusion protein antigen and preparation process and use thereof
Publication Number
公开号
1450087 Publication Date
公开日
2003.10.22
Approval Pub. Date Granted Pub. Date 2005.03.30
International Classification 分类号 C07K19/00,C12N15/62,C12N15/63
Applicant(s) Name
申请人
Li Yuexi
Address 地址 210002
Inventor(s) Name 发明人 Li Yuexi
Attorney & Agent 代理人 xi shengyuan

  
Recombination human cytomegalovirus fusion protein and its preparing method, application
Detection type gene chip for detecting various infectious desease and use thereof
Chemosynthesized SARS virus S gene segement, its expression and application
SARS virus S protein and N protein fusion protein, and preparation and use thereof
Virus in deactivated bioproduct and method of removing toxin in bacteria
Novel method for producing carragheen
Metallocene titanium compound and use thereof
Benzene free type fluorocarbon resin
Ultralow surface energy type fluorocarbon resin
Polymer particle stabilized by dispersant and method of preparation
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.